McCann Corey 4
4 · Pear Therapeutics, Inc. · Filed Feb 17, 2023
Insider Transaction Report
Form 4
McCann Corey
DirectorPresident and CEO
Transactions
- Award
Restricted Stock Units
2023-02-15+2,857,142→ 2,857,142 total→ Class A Common Stock (2,857,142 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of PEAR Class A Common Stock.
- [F2]The restricted stock units shall vest and settle as to 33% on February 15, 2024; 33% on February 15, 2025; and 34% on February 15, 2026.